Vyome Holdings, Inc

Name: Vyome Holdings, Inc standardized financial statements, quarterly
Creator: Listed

HINDNasdaqCIK 1427570HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$27.0k, Q2 FY2026

Operating income−$862.6k, Q2 FY2026

Net income−$685.6k, Q2 FY2026

Vyome Holdings, Inc, income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	2,155	1,982	1,944	1,965	2,292	1,805	1,113	1,242	34.6	36.6	31.6	27.0
Cost of revenue	$k	867	140	779	831	47.4	(1.3)	44.2	25.7	16.6	14.5	14.9	15.3
Gross profit	$k	1,288	1,842	1,165	1,134	37.1	62.8	154	24.2	18.1	22.1	16.6	11.7
Research and development	$k	542	739	484	399	66.8	67.5	90.3	80.1	39.7	378	666	507
Selling, general and administrative	$k	1,791	1,398	1,019	670	247	247	260	265	844	996	478	365
Operating income	$k	(3,880)	(1,895)	(2,210)	(2,054)	(281)	(256)	(199)	(324)	(8,574)	(1,355)	(1,130)	(863)
Interest expense	$k	not reported	not reported	not reported	not reported	45.7	52.8	55.0	56.1	25.6	9.9	2.8	3.3
Income tax	$k	3.0	31.0	14.0	15.0	6.0	5.0	7.0	8.0	not reported	not reported	not reported	not reported
Net income	$k	(3,534)	(1,698)	(2,193)	(1,595)	(548)	(307)	(294)	(309)	(8,434)	(1,225)	(963)	(686)
Diluted EPS	$ per share	(59.36)	not reported	(135.37)	(91.56)	(1419.10)	not reported	(761.59)	(799.90)	(3.12)	not reported	(0.15)	(0.10)
Basic EPS	$ per share	(59.36)	not reported	(135.37)	(91.56)	(1419.10)	not reported	(761.59)	(799.90)	(3.12)	not reported	(0.15)	(0.10)

Balance sheet

Cash and equivalents$7.9m, Q2 FY2026

Shareholders' equity$7.3m, Q2 FY2026

Vyome Holdings, Inc, balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	1.4	4.5	2.4	0.0	0.7	0.1	2.5	4.1	5.7	5.0	8.8	7.9
Current assets	$m	7.4	10.3	7.9	6.1	5.3	0.3	6.3	8.9	6.0	5.4	9.2	8.2
Total assets	$m	7.8	10.7	8.2	6.4	1.3	1.4	1.4	9.0	7.0	6.5	10.2	9.2
Current liabilities	$m	4.5	3.8	3.5	3.2	4.0	5.7	4.1	3.2	3.1	2.7	2.1	1.9
Total liabilities	$m	4.7	4.0	3.7	3.4	4.1	5.8	5.3	3.2	3.1	2.7	2.1	1.9
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	0.8	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	3.1	6.7	4.5	3.0	1.5	(4.4)	1.2	5.8	2.5	3.8	8.0	7.3

Cash flow

Operating cash flow−$903.7k, Q2 FY2026

Capital expenditure$0, Q4 FY2023

Vyome Holdings, Inc, cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(2,780)	(2,457)	(2,072)	(1,357)	2,818	(3.0)	(204)	(306)	(1,761)	(1,478)	(1,436)	(904)
Capital expenditure	$k	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)6.69m, Q1 FY2026

Vyome Holdings, Inc, shares, quarterly
Line item	Unit	Q2 FY20222022-06-30	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31
Diluted shares (weighted)	k shares	386	451	1,708	3,249	59.5	16.2	17.4	0.4	0.4	1,169	2,758	6,690

Shares outstanding: 7.02m at Aug 12, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.